Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

A randomized controlled safety and feasibility trial of floatation-REST in anxious and depressed individuals

McKenna M. Garland, Raminta Wilson, Wesley K. Thompson, View ORCID ProfileMurray B. Stein, View ORCID ProfileMartin P. Paulus, Justin S. Feinstein, View ORCID ProfileSahib S. Khalsa
doi: https://doi.org/10.1101/2023.05.27.23290633
McKenna M. Garland
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
bKendall College of Arts and Sciences, University of Tulsa, Tulsa, Oklahoma
M.A.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Raminta Wilson
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
M.D., M.P.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Wesley K. Thompson
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Murray B. Stein
cDepartment of Psychiatry, University of California San Diego, La Jolla, California
dHerbert Wertheim School of Public Health and Human Longevity Science, University of California San Diego, La Jolla, California
ePsychiatry Service, Veterans Affairs San Diego Healthcare System, San Diego, California
M.D., M.P.H.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Murray B. Stein
Martin P. Paulus
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
fOxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma
M.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Martin P. Paulus
Justin S. Feinstein
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
fOxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma
gFloat Research Collective, Kihei, Hawaii
Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sahib S. Khalsa
aLaureate Institute for Brain Research, University of Tulsa, Tulsa, Oklahoma
fOxley College of Health Sciences, University of Tulsa, Tulsa, Oklahoma
M.D., Ph.D.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Sahib S. Khalsa
  • For correspondence: skhalsa@laureateinstitute.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

Background Reduced Environmental Stimulation Therapy via floatation (floatation-REST) is a behavioral intervention designed to attenuate exteroceptive sensory input to the nervous system. Pilot studies in anxious and depressed individuals demonstrated that single sessions of floatation- REST are safe, well-tolerated, and associated with acute anxiolysis. However, there is not sufficient evidence of the feasibility of floatation-REST as a repeated intervention.

Methods We randomized 75 individuals with anxiety and depression to six sessions of floatation-REST in different formats (pool-REST or pool-REST preferred) or an active comparator (chair-REST). Feasibility was assessed via adherence rate to the assigned intervention, tolerability via duration of REST utilization and overall study dropout rate, and safety via incidence of serious or non-serious adverse events.

Results Six-session adherence was 85% for pool-REST, 89% for pool-REST preferred, and 74% for chair-REST. Dropout rates did not differ significantly between the treatment conditions.

Mean session durations were consistently above 50 minutes, and when allowed to choose the duration and frequency, participants opted to float for an average of 75 minutes. There were no serious adverse events associated with any intervention. Positive experiences were endorsed more commonly than negative ones and were also rated at higher levels of intensity.

Conclusions Taken together, six sessions of floatation-REST appear feasible, well-tolerated, and safe in anxious and depressed individuals. Floatation-REST induces positively-valenced experiences with few negative effects. Larger randomized controlled trials evaluating markers of clinical efficacy are warranted.

Clinical Trial Registration Identifier NCT03899090

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

ClinicalTrials.gov NCT03899090

Clinical Protocols

https://clinicaltrials.gov/ct2/show/NCT03899090

Funding Statement

This research was supported by an award from the National Center for Complimentary and Integrative Health (R34AT009889). The authors were also supported by the National Institute of Mental Health (R01MH127225, K23MH112949 to SSK), National Institute of General Medical Sciences Center Grant Award Number (1P20GM121312 to MPP, JSF, SSK), and The William K. Warren Foundation. The funding sources had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

All study procedures were approved by the Western Institutional Review Board (Protocol #: 20150528) and were performed in accordance with Declaration of Helsinki. All participants provided their written informed consent prior to participation and were compensated for their study involvement.

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Footnotes

  • A sentence fragment was removed from the abstract.

Data Availability

All data produced in the present study are available upon reasonable request to the authors.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted June 08, 2023.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
A randomized controlled safety and feasibility trial of floatation-REST in anxious and depressed individuals
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
A randomized controlled safety and feasibility trial of floatation-REST in anxious and depressed individuals
McKenna M. Garland, Raminta Wilson, Wesley K. Thompson, Murray B. Stein, Martin P. Paulus, Justin S. Feinstein, Sahib S. Khalsa
medRxiv 2023.05.27.23290633; doi: https://doi.org/10.1101/2023.05.27.23290633
Reddit logo Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
A randomized controlled safety and feasibility trial of floatation-REST in anxious and depressed individuals
McKenna M. Garland, Raminta Wilson, Wesley K. Thompson, Murray B. Stein, Martin P. Paulus, Justin S. Feinstein, Sahib S. Khalsa
medRxiv 2023.05.27.23290633; doi: https://doi.org/10.1101/2023.05.27.23290633

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Psychiatry and Clinical Psychology
Subject Areas
All Articles
  • Addiction Medicine (270)
  • Allergy and Immunology (552)
  • Anesthesia (135)
  • Cardiovascular Medicine (1757)
  • Dentistry and Oral Medicine (238)
  • Dermatology (173)
  • Emergency Medicine (312)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (659)
  • Epidemiology (10799)
  • Forensic Medicine (8)
  • Gastroenterology (590)
  • Genetic and Genomic Medicine (2949)
  • Geriatric Medicine (287)
  • Health Economics (534)
  • Health Informatics (1928)
  • Health Policy (836)
  • Health Systems and Quality Improvement (745)
  • Hematology (292)
  • HIV/AIDS (630)
  • Infectious Diseases (except HIV/AIDS) (12517)
  • Intensive Care and Critical Care Medicine (690)
  • Medical Education (299)
  • Medical Ethics (86)
  • Nephrology (324)
  • Neurology (2799)
  • Nursing (151)
  • Nutrition (433)
  • Obstetrics and Gynecology (559)
  • Occupational and Environmental Health (597)
  • Oncology (1466)
  • Ophthalmology (444)
  • Orthopedics (172)
  • Otolaryngology (257)
  • Pain Medicine (190)
  • Palliative Medicine (56)
  • Pathology (381)
  • Pediatrics (866)
  • Pharmacology and Therapeutics (366)
  • Primary Care Research (337)
  • Psychiatry and Clinical Psychology (2640)
  • Public and Global Health (5366)
  • Radiology and Imaging (1013)
  • Rehabilitation Medicine and Physical Therapy (595)
  • Respiratory Medicine (726)
  • Rheumatology (330)
  • Sexual and Reproductive Health (289)
  • Sports Medicine (279)
  • Surgery (327)
  • Toxicology (47)
  • Transplantation (150)
  • Urology (125)